These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31394999)

  • 41. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
    Bannai H; Tsujimura K; Kondo T; Nemoto M; Yamanaka T; Sugiura T; Maeda K; Matsumura T
    J Vet Med Sci; 2011 Apr; 73(4):535-9. PubMed ID: 21139350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurologic form of rhinopneumonia].
    Sloet van Oldruitenborgh-Oosterbaan M
    Tijdschr Diergeneeskd; 2005 Oct; 130(20):629-31. PubMed ID: 16276730
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of equine herpesvirus type 4 glycoprotein k in virus replication.
    Azab W; El-Sheikh A
    Viruses; 2012 Aug; 4(8):1258-63. PubMed ID: 23012623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The full genome sequences of 8 equine herpesvirus type 4 isolates from horses in Japan.
    Izume S; Kirisawa R; Ohya K; Ohnuma A; Kimura T; Omatsu T; Katayama Y; Mizutani T; Fukushi H
    J Vet Med Sci; 2017 Jan; 79(1):206-212. PubMed ID: 27840393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative molecular viral loads in 7 horses with naturally occurring equine herpesvirus-1 infection.
    Estell KE; Dawson DR; Magdesian KG; Swain E; Laing ST; Siso S; Mapes S; Pusterla N
    Equine Vet J; 2015 Nov; 47(6):689-93. PubMed ID: 25212737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
    Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
    Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Latent equine herpesvirus-1 in trigeminal ganglia and equine idiopathic headshaking.
    Aleman M; Pickles KJ; Simonek G; Madigan JE
    J Vet Intern Med; 2012; 26(1):192-4. PubMed ID: 22211434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a peptide ELISA for discrimination between serological responses to equine herpesvirus type 1 and 4.
    Lang A; de Vries M; Feineis S; Müller E; Osterrieder N; Damiani AM
    J Virol Methods; 2013 Nov; 193(2):667-73. PubMed ID: 23928223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
    Frampton AR; Goins WF; Cohen JB; von Einem J; Osterrieder N; O'Callaghan DJ; Glorioso JC
    J Virol; 2005 Mar; 79(5):3169-73. PubMed ID: 15709036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical insights: Equine herpesvirus myeloencephalopathy: The conundrum of vaccination in performance and leisure horses.
    Kydd JH
    Equine Vet J; 2021 Nov; 53(6):1088-1090. PubMed ID: 34611933
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of latent alpha-herpesviruses in Thoroughbred racing horses.
    Pusterla N; Mapes S; David Wilson W
    Vet J; 2012 Aug; 193(2):579-82. PubMed ID: 22405721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand.
    McFadden AM; Hanlon D; McKenzie RK; Gibson I; Bueno IM; Pulford DJ; Orr D; Dunowska M; Stanislawek WL; Spence RP; McDonald WL; Munro G; Mayhew IG
    N Z Vet J; 2016 Mar; 64(2):125-34. PubMed ID: 26414406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abortion due to equine herpesvirus in southern Brazil.
    Weiblen R; Rabuske M; Rebelatto MC; Nobre VM; Canabarro TF
    Braz J Med Biol Res; 1994 Jun; 27(6):1317-20. PubMed ID: 7894345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
    Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
    Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary vasculotropic EHV-1 infection in equids.
    Del Piero F; Wilkins PA
    Vet Pathol; 2001 Jul; 38(4):474. PubMed ID: 11467487
    [No Abstract]   [Full Text] [Related]  

  • 60. Disease remission in a horse with EHV-5-associated lymphoma.
    Vander Werf K; Davis E
    J Vet Intern Med; 2013; 27(2):387-9. PubMed ID: 23458852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.